944.F BIOMAXIMA SA ZY 1
- Market cap
- EUR 6.93M
- P/E
- 33.0x
- P/B
- 0.63x
- ROE
- 2.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 944.F undervalued?
Graham number944.F trades 3.9% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BIOMAXIMA SA ZY 1 fundamental analysis
No fundamental analysis for BIOMAXIMA SA ZY 1 yet.
BIOMAXIMA SA ZY 1 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BIOMAXIMA SA ZY 1
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which include real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibio…
Full company profileBIOMAXIMA SA ZY 1 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BIOMAXIMA SA ZY 1 annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 79.1M | 144M | 46.8M | 52.9M | 60.9M | 55.8M |
| Gross Profit | 29.0M | 54.2M | 20.0M | 23.3M | 26.7M | 29.5M |
| Operating Income | 13.1M | 34.7M | -239K | 1.11M | 961K | 1.23M |
| EBITDA | - | 38.4M | 3.28M | 4.65M | 5.08M | 6.67M |
| Net Income | 10.2M | 28.9M | 586K | 535K | 105K | 1.38M |
| EPS | 2.37 | 6.96 | 0.14 | 0.13 | 0.03 | 0.33 |
| Balance Sheet | ||||||
| Total Assets | 61.9M | 74.4M | 73.8M | 76.3M | 77.5M | 79.7M |
| Total Liabilities | 32.7M | 22.0M | 26.8M | 29.0M | 29.4M | 31.4M |
| Shareholders' Equity | 29.2M | 52.5M | 47.0M | 47.3M | 48.1M | 48.3M |
| Cash & Short-term Investments | 3.00M | 12.9M | 1.50M | 909K | 1.74M | 1.20M |
| Cash Flow | ||||||
| Operating Cash Flow | -132K | 37.1M | 1.59M | -152K | 3.37M | -3.89M |
| Capital Expenditure | 4.48M | 9.88M | 18.1M | 2.27M | 999K | 608K |
| Free Cash Flow | -4.61M | 27.2M | -16.5M | -2.42M | 2.38M | -4.50M |
| Ratios | ||||||
| ROE | 35.1% | 55.1% | 1.2% | 1.1% | 0.2% | 2.9% |
| ROA | 16.5% | 38.8% | 0.8% | 0.7% | 0.1% | 1.7% |
| Net Profit Margin | 13.0% | 20.1% | 1.3% | 1.0% | 0.2% | 2.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
BIOMAXIMA SA ZY 1 dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 16, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | PLN 2.10M | 0.50 | 357.8% |
| 2022 | PLN 1.95M | 0.47 | 6.7% |
| 2021 | PLN 1.10M | 0.25 | 10.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns BIOMAXIMA SA ZY 1
- Insiders 34.41%
- Institutions 0.05%
- Public & others 65.54%
- Shares outstanding 4.19M
- Free float 2.26M
BIOMAXIMA SA ZY 1 company profile
- Company name
- BIOMAXIMA SA ZY 1
- Ticker
- 944.F
- ISIN
- PLBIOMX00015
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 143
- Fiscal year end
- December
- Address
- ul. Vetterów 5, Lublin, Poland, 20-277
- Phone
- 48 81 440 83 71
- Website
- biomaxima.com
About BIOMAXIMA SA ZY 1
BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which include real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in vitro cultures, phenotypic micromatrices, plastics and small equipment, basic substrate components, and form. In addition, it offers laboratory diagnostics solutions for various areas of clinical chemistry, haematology, coagulology, immunochemistry, POCT, rapid tests, and blood collection systems; and disposable materials comprising microbiology, dispensing equipment, tubes, plugs, tripods, capillaries, equipment, aspiration-vacuum system, containers, tank for analysers, urine analysis, microscope slides, reagent tubes, and autoclave equipment. BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.
BIOMAXIMA SA ZY 1 management
4- Mr. Lukasz UrbanPresident of the Management Board · born 1971
- Mr. Henryk LewczukCFO & Member of the Management Board
- Mr. Piotr JanowskiCOO & Member of the Management Board
- Zaneta HomendaChief Accounting Officer